Zdrowie i gospodarka · 04/10/2007
FDA Proposes Changes to Electrocardiograph Electrode Device Classification
The FDA is proposing to exempt the electrocardiograph electrode device from premarket notification requirements and establish special controls to ensure its safety and effectiveness, with a draft guidance document available for public review.
Source: Federal Register — Food and Drug AdministrationOpen original release →